Abstract
In September 2019, immediate past chair of the American Society for Radiation Oncology (ASTRO) Board of Directors, Dr Brian Kavanagh, published an editorial in the Red Journal entitled “Radiation Oncology APM: Why Us? Why Now?”1 This was a thoughtful look at the rationale for engaging with the Centers for Medicare and Medicaid Services (CMS) to create a payment model for our specialty that was both fair and predictable, placing value over volume. In the wake of the posting of the Radiation Oncology Model (RO model) Final Rule, I believe that it is critical to follow up on Dr Kavanagh’s hopeful comments and ASTRO’s response to the emerging model.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology*Biology*Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
